3SBio Inc. announced changes to its board of directors. Mr. Lawrence Wizel has submitted his resignation from 3SBio's board of directors, effective September 1, 2012. Mr. Wizel has served as an independent director since 2006.

At the time of his resignation Mr. Wizel was the chair of the audit committee and a member of the compensation committee and the investment committee. Effective September 1, 2012, Mr. Tianruo (Robert) Pu will join 3SBio's board of directors as an independent director, with appointment to serve in the audit committee as the chair and in the compensation committee. Mr. Pu currently chairs the audit committee of UTStarcom Holdings Corp.

and also serves on its other board committees. From September 2008 to June 2012, Mr. Pu was the chief financial officer of China Nuokang Bio-Pharmaceutical Inc. where he successfully led Nuokang Biopharma's IPO process and was responsible for its M&A and corporate growth strategy.